Celnovte's CD138(C5G6) on Automatic IHC stainer CNT360 is honored as recommendation from NordiQC

Celnovte has consistently received excellent results in the international authoritative pathology quality assessment organizations—NordiQC Immunohistochemistry.

Last year, all antibodies submitted by Celnvote for evaluation achieved exceptional results including #HER2, #ER, #PD-L1 (TPS/CPS), #CK8/18, #PSA, #CD138, #CD5, #CD10, #MSH2, #TTF1, #p40, and #p53.

HER2

In this assessment, 419 laboratories participated, achieving a pass rate of 86%, with 53% rated as excellent.

ER

In this assessment, 440 laboratories participated, achieving a pass rate of 78%, with 22% rated as excellent.

PD-L1 (TPS/CPS)

In this assessment, 243 laboratories participated, achieving a pass rate of 69%, with 32% rated as excellent.

CK8/18

In this assessment, 282 laboratories participated, achieving a pass rate of 85%, with 65% rated as excellent.

PSA

In this assessment, 377 laboratories participated, achieving a pass rate of 85%, with 50% rated as excellent.

CD138

In this assessment, 386 laboratories participated, achieving a pass rate of 86%, with 60% rated as excellent.

CD5

In this assessment, 379 laboratories participated, achieving a pass rate of 72%, with 54% rated as excellent.

CD10

In this assessment, 403 laboratories participated, achieving a pass rate of 73%, with 48% rated as excellent.

MSH2

In this assessment, 350 laboratories participated, achieving a pass rate of 91%, with 62% rated as excellent.

TTF1

In this assessment, 401 laboratories participated, achieving a pass rate of 81%, with 71% rated as excellent.

p40

In this assessment, 343 laboratories participated, achieving a pass rate of 85%, with 60% rated as excellent.

p53

In this assessment, 372 laboratories participated, achieving a pass rate of 65%, with 29% rated as excellent.

#IHC #CD138 #automation #slidestainer #pathology #diagnostic

[email protected]